Upcoming Events

ISMRM Workshop on MR Value Mar 11, 2019 - Mar 13, 2019 — University of Edinburgh
European Molecular Imaging Meeting 2019 Mar 19, 2019 - Mar 22, 2019 — Scottish Event Campus, Glasgow
Edinburgh SPM Course 2019 Apr 01, 2019 - Apr 05, 2019 — University of Edinburgh
RiiSE19 Conference Apr 13, 2019 12:00 AM — Central Edinburgh
Scottish Radiological Society Spring Meeting 2019 May 17, 2019 09:00 AM - 05:00 PM — McDiarmid Park, Perth

SINAPSE Image of the Month: Liver T1 mapping

October 2017 SINAPSE Image of the Month

Courtesy of Dr Jonathan Fallowfield, this image shows LiverMultiscan MRI axial T1 relaxation maps of liver in the same patient before [left] and 4 weeks after [right] treatment of portal hypertension with non-selective beta-blockers (NSBBs). Top row shows representative image of liver T1 relaxation map from a single patient; position of 3 regions of interest is indicated by white circles. Bottom row shows corresponding segmented liver histograms and T1 colour scales. Numbers below each histogram represent the mode T1.

Non-invasive biomarkers are urgently needed for diagnosis, monitoring and evaluating treatment response in patients with portal hypertension (a condition which underlies most of the lethal complications of liver cirrhosis such as variceal bleeding). The image is taken from a recent study published in BioMed Research International, reporting the first use of quantitative MRI markers (phase-contrast MR angiography and T1 mapping) for the haemodynamic assessment of NSBBs in portal hypertension in a small randomized feasibility study:

McDonald N, Lilburn DML, Lachlan NJ, Macnaught G, Patel D, Jayaswal ANA, Hayes PC, Semple SI, Fallowfield JA. Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography. BioMed Research International, 2017, 9281450.